IASLC Global Survey for Pathologists on PD-L1 Testing for Non-Small Cell Lung Cancer

被引：2

作者：

Mino-Kenudson, M. ^{[1
]}

Redman, M. ^{[2
]}

Hedger, J. ^{[3
]}

Daigneault, J. ^{[3
]}

Botling, J. ^{[4
]}

Brambilla, E. ^{[5
]}

Chen, G. ^{[6
]}

Chou, T. ^{[7
]}

Cooper, W. ^{[8
]}

Hirsch, F. R. ^{[9
]}

Jain, D. ^{[10
]}

Kerr, K. ^{[11
]}

Longshore, J. ^{[12
]}

Lopez-Rios, F. ^{[13
]}

Motoi, N. ^{[14
]}

Pelosi, G. ^{[15
]}

Tsao, M. ^{[16
]}

Yatabe, Y. ^{[17
]}

Beasley, M. B. ^{[18
]}

Borczuk, A. ^{[19
]}

Bubendorf, L. ^{[20
]}

Chung, J. ^{[21
]}

Dacic, S. ^{[22
]}

Hwang, D. ^{[23
]}

Minami, Y. ^{[24
]}

Moreira, A. ^{[25
]}

Nicholson, A. ^{[26
]}

Papotti, M. ^{[27
]}

Poleri, C.

Rekhtman, N. ^{[28
]}

Roden, A. C. ^{[29
]}

Russell, P. ^{[30
]}

Sholl, L. ^{[31
]}

Thunnissen, E. ^{[32
]}

Travis, W. ^{[28
]}

Yoshida, A. ^{[33
]}

Wynes, M. ^{[34
]}

Wistuba, I. ^{[35
]}

Lantuejoul, S. ^{[36
]}

机构：

[1] Massachusetts Gen Hosp, Pathol, Boston, MA 02114 USA

[2] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA

[3] Int Assoc Study Lung Canc, Denver, CO USA

[4] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden

[5] Ctr Hosp Univ Grenoble, Dept Anat & Cytol Pathol, Grenoble, France

[6] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China

[7] Taipei Vet Gen Hosp, Taipei, Taiwan

[8] Royal Prince Alfred Hosp, Camperdown, NSW, Australia

[9] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[10] All India Inst Med Sci, Pathol, New Delhi, India

[11] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland

[12] Carolinas Pathol Grp, Charlotte, NC USA

[13] Hosp Univ Sanchinarro, Madrid, Spain

[14] Natl Canc Ctr, Dept Pathol, Tokyo, Japan

[15] Univ Milan, Milan, Italy

[16] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[17] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan

[18] Mt Sinai Hlth Syst, Icahn Sch Med, Pathol, New York, NY USA

[19] Weill Cornell, New York, NY USA

[20] Univ Basel, Basel, Switzerland

[21] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea

[22] Univ Pittsburgh, Pittsburgh, PA USA

[23] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[24] Natl Hosp Org, Ibaraki Higashi Natl Hosp, Dept Pathol, Ctr Chest Dis & Severe Motor & Intellectual Disab, Tokai, Ibaraki, Japan

[25] NYU, Sch Med, New York, NY USA

[26] Royal Brompton & Harefield NHS Trust, Dept Histopathol, London, England

[27] Univ Turin, Turin, Italy

[28] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[29] Mayo Clin Rochester, Lab Med & Pathol, Rochester, AL USA

[30] St Vincents Hosp, Fitzroy, Vic, Australia

[31] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA

[32] Vrije Univ Amsterdam Med Ctr, Pathol, Amsterdam, Netherlands

[33] Natl Canc Ctr, Tokyo, Japan

[34] Int Assoc Study Lung Canc, Aurora, CO USA

[35] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[36] Ctr Leon Berard, Lyon, France

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

global survey; NSCLC; PD-L1; immunohistochemistry;

D O I：

10.1016/j.jtho.2019.08.1673

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.09-24

引用

页码：S778 / S779

页数：2

共 50 条

[1] Impact of Specimen Characteristics on PD-L1 Testing in Non-Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing Recommendations
Gagne, Andreanne
Wang, Emily
Bastien, Nathalie
Orain, Michele
Desmeules, Patrice
Page, Sylvain
Trahan, Sylvain
Couture, Christian
Joubert, David
Joubert, Philippe
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : 2062 - 2070
[2] PREDICTORS OF PD-L1 TESTING IN NON-SMALL CELL LUNG CANCER
DiBonaventura, M.
Meyers, A.
Higginbottom, K.
Morimoto, Y.
Ilacqua, J.
VALUE IN HEALTH, 2016, 19 (07) : A763 - A763
[3] PD-L1 expression testing in non-small cell lung cancer
Teixido, Cristina
Vilarino, Noelia
Reyes, Roxana
Reguart, Noemi
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
[4] Challenges of PD-L1 testing in non-small cell lung cancer and beyond
Wang, Minyu
Wang, Sen
Trapani, Joseph A.
Neeson, Paul J.
JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4541 - 4548
[5] Non-Small Cell Lung Cancer, PD-L1, and the Pathologist
Kerr, Keith M.
Nicolson, Marianne C.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (03) : 249 - 254
[6] PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?
Grigg, Claud
Rizvi, Naiyer A.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
[7] Harmonization of Molecular Testing for Non-Small Cell Lung Cancer: Emphasis on PD-L1
Imyanitov, Evgeny N.
Ivantsov, Alexandr O.
Tsimafeyeu, Ilya, V
FRONTIERS IN ONCOLOGY, 2020, 10
[8] PD-L1 Testing in Non-small Cell Lung Cancer: Past, Present, and Future
Kim, Hyojin
Chung, Jin-Haeng
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2019, 53 (04) : 199 - 206
[9] Histology versus cytology: PD-L1 testing in non-small cell lung cancer
Takigawa, Nagio
Ochi, Nobuaki
Yamane, Hiromichi
TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S225 - S227
[10] PD-L1 testing in non-small cell lung carcinoma: Guidelines from the PATTERN group of thoracic pathologists
Lantuejoul, Sylvie
Adam, Julien
Girard, Nicolas
Duruisseaux, Mickael
Mansuet-Lupo, Audrey
Cazes, Aurelie
Rouquette, Isabelle
Gibault, Laure
Garcia, Stephane
Antoine, Martine
Vignaud, Jean Michael
Galateau-Salle, Francoise
Sagan, Christine
Badoual, Cecile
Penault-Llorca, Frederique
Damotte, Diane
ANNALES DE PATHOLOGIE, 2018, 38 (02) : 110 - 125

← 1 2 3 4 5 →